| Literature DB >> 29396681 |
Andrés Coca-Pelaz1, Robert P Takes2, Kate Hutcheson3, Nabil F Saba4, Missak Haigentz5, Carol R Bradford6, Remco de Bree7, Primož Strojan8, Valerie J Lund9, William M Mendenhall10, Iain J Nixon11, Miquel Quer12, Alessandra Rinaldo13, Alfio Ferlito14.
Abstract
Delay between the initial symptoms, diagnosis, and the definitive treatment of head and neck cancers is associated with tumor progression and upstaging. These delays may lead to poor outcomes and may mandate more aggressive treatments with unnecessary morbidity and even mortality. The multidisciplinary team approach for the treatment of patients with head and neck cancers has improved organization of standard clinical guidelines, but this development has yet to translate into a demonstrable impact on survival. We review the association between waiting times (time between diagnosis and initiation of treatment) and clinical outcomes in patients with head and neck squamous cell carcinoma (HNSCC).Entities:
Keywords: Head and neck cancer; Oncology; Prognosis; Survival; Treatment; Waiting time
Mesh:
Year: 2018 PMID: 29396681 DOI: 10.1007/s12325-018-0663-7
Source DB: PubMed Journal: Adv Ther ISSN: 0741-238X Impact factor: 3.845